Ambrx
Barney Barnett has over 25 years of work experience in the biotechnology industry. Barney started their career at IDEC in 1992 as a Scientist and worked there until 2003 when they joined Biogen Idec. Barney then moved to the Genomics Institute of the Novartis Research Institute in 2006 as a Research Investigator before joining Ambrx in 2007 as a Lead Scientist. In 2014, Barney Barnett started working independently.
Barney Barnett obtained a Ph.D. in Molecular Biology from the University of Kentucky.
Ambrx
Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Ambrx is based on a fundamental advance in protein biosynthesis that enables the company to genetically engineer proteins with new amino acid building blocks beyond the common twenty, enabling the biosynthesis of proteins with new physical, chemical and pharmacological properties.